170 related articles for article (PubMed ID: 18417529)
1. Identification of an INSM1-binding site in the insulin promoter: negative regulation of the insulin gene transcription.
Wang HW; Muguira M; Liu WD; Zhang T; Chen C; Aucoin R; Breslin MB; Lan MS
J Endocrinol; 2008 Jul; 198(1):29-39. PubMed ID: 18417529
[TBL] [Abstract][Full Text] [Related]
2. INSM1 functions as a transcriptional repressor of the neuroD/beta2 gene through the recruitment of cyclin D1 and histone deacetylases.
Liu WD; Wang HW; Muguira M; Breslin MB; Lan MS
Biochem J; 2006 Jul; 397(1):169-77. PubMed ID: 16569215
[TBL] [Abstract][Full Text] [Related]
3. Zinc finger transcription factor INSM1 interrupts cyclin D1 and CDK4 binding and induces cell cycle arrest.
Zhang T; Liu WD; Saunee NA; Breslin MB; Lan MS
J Biol Chem; 2009 Feb; 284(9):5574-81. PubMed ID: 19124461
[TBL] [Abstract][Full Text] [Related]
4. Insulinoma-associated antigen-1 zinc-finger transcription factor promotes pancreatic duct cell trans-differentiation.
Zhang T; Wang H; Saunee NA; Breslin MB; Lan MS
Endocrinology; 2010 May; 151(5):2030-9. PubMed ID: 20215568
[TBL] [Abstract][Full Text] [Related]
5. Extra-nuclear activity of INSM1 transcription factor enhances insulin receptor signaling pathway and Nkx6.1 expression through RACK1 interaction.
Zhang T; Chen C; Breslin MB; Song K; Lan MS
Cell Signal; 2014 Apr; 26(4):740-7. PubMed ID: 24407176
[TBL] [Abstract][Full Text] [Related]
6. The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor.
Li Y; Shen Q; Kim HT; Bissonnette RP; Lamph WW; Yan B; Brown PH
Breast Cancer Res Treat; 2011 Aug; 128(3):667-77. PubMed ID: 20821348
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression.
Senawong T; Peterson VJ; Avram D; Shepherd DM; Frye RA; Minucci S; Leid M
J Biol Chem; 2003 Oct; 278(44):43041-50. PubMed ID: 12930829
[TBL] [Abstract][Full Text] [Related]
8. SOX6 suppresses cyclin D1 promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferation.
Iguchi H; Urashima Y; Inagaki Y; Ikeda Y; Okamura M; Tanaka T; Uchida A; Yamamoto TT; Kodama T; Sakai J
J Biol Chem; 2007 Jun; 282(26):19052-61. PubMed ID: 17412698
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific promoter-driven adenoviral therapy for insulinoma.
Tseng AW; Chen C; Breslin MB; Lan MS
Cell Oncol (Dordr); 2016 Jun; 39(3):279-86. PubMed ID: 26902080
[TBL] [Abstract][Full Text] [Related]
10. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer.
Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS
Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225
[TBL] [Abstract][Full Text] [Related]
11. Insm1 promotes endocrine cell differentiation by modulating the expression of a network of genes that includes Neurog3 and Ripply3.
Osipovich AB; Long Q; Manduchi E; Gangula R; Hipkens SB; Schneider J; Okubo T; Stoeckert CJ; Takada S; Magnuson MA
Development; 2014 Aug; 141(15):2939-49. PubMed ID: 25053427
[TBL] [Abstract][Full Text] [Related]
12. Paired-homeodomain transcription factor PAX4 acts as a transcriptional repressor in early pancreatic development.
Smith SB; Ee HC; Conners JR; German MS
Mol Cell Biol; 1999 Dec; 19(12):8272-80. PubMed ID: 10567552
[TBL] [Abstract][Full Text] [Related]
13. Insm1 controls development of pituitary endocrine cells and requires a SNAG domain for function and for recruitment of histone-modifying factors.
Welcker JE; Hernandez-Miranda LR; Paul FE; Jia S; Ivanov A; Selbach M; Birchmeier C
Development; 2013 Dec; 140(24):4947-58. PubMed ID: 24227653
[TBL] [Abstract][Full Text] [Related]
14. Binding of activating transcription factor 6 to the A5/Core of the rat insulin II gene promoter does not mediate its transcriptional repression.
Amyot J; Benterki I; Fontés G; Hagman DK; Ferdaoussi M; Teodoro T; Volchuk A; Joly É; Poitout V
J Mol Endocrinol; 2011 Dec; 47(3):273-83. PubMed ID: 21821716
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
[TBL] [Abstract][Full Text] [Related]
16. Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation.
Lan MS; Breslin MB
FASEB J; 2009 Jul; 23(7):2024-33. PubMed ID: 19246490
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine differentiation factor, IA-1, is a transcriptional repressor and contains a specific DNA-binding domain: identification of consensus IA-1 binding sequence.
Breslin MB; Zhu M; Notkins AL; Lan MS
Nucleic Acids Res; 2002 Feb; 30(4):1038-45. PubMed ID: 11842116
[TBL] [Abstract][Full Text] [Related]
18. Neurogenin 3 recruits CBP co-activator to facilitate histone H3/H4 acetylation in the target gene INSM1.
Breslin MB; Wang HW; Pierce A; Aucoin R; Lan MS
FEBS Lett; 2007 Mar; 581(5):949-54. PubMed ID: 17300785
[TBL] [Abstract][Full Text] [Related]
19. Insulinoma-associated protein 1 controls nasopharyngeal carcinoma to radiotherapy by modulating cyclin D1-dependent DNA repair machinery.
Song R; Wei X; Wang Y; Hu S; Ba Y; Xiao X; Zhang J
Carcinogenesis; 2020 May; 41(3):326-333. PubMed ID: 31155641
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment.
Fu M; Rao M; Bouras T; Wang C; Wu K; Zhang X; Li Z; Yao TP; Pestell RG
J Biol Chem; 2005 Apr; 280(17):16934-41. PubMed ID: 15713663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
